Guardant Health, Inc.
Guardant Health, Inc. (GH) Revenue
Annual & quarterly revenue history · segment & region breakdown
GH · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsGuardant Health, Inc. trailing twelve-month (TTM) revenue is $1.08B, an increase of 32.88% year-over-year from $0.98B in FY2025.
Revenue trend
2025 – 2016 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.98B | +$0.24B | +32.88% |
| 2024-12-31 | $0.74B | +$0.18B | +31.04% |
| 2023-12-31 | $0.56B | +$0.11B | +25.45% |
| 2022-12-31 | $0.45B | +$0.08B | +20.31% |
| 2021-12-31 | $0.37B | +$0.09B | +30.32% |
| 2020-12-31 | $0.29B | +$0.07B | +33.75% |
| 2019-12-31 | $0.21B | +$0.12B | +136.52% |
| 2018-12-31 | $0.09B | +$0.04B | +81.85% |
| 2017-12-31 | $0.05B | +$0.02B | +97.40% |
| 2016-12-31 | $0.03B | — | — |
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare GH revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Guardant Health, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Guardant Health, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Guardant Health, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GH revenue · 4 questionsGH's trailing twelve-month (TTM) revenue is $1.08B. That is an increase of 32.88% year-over-year from $0.98B in FY2025.
▸ Source: FMP · Guardant Health, Inc. SEC filings · GAAP · Guardant Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026